Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
acetylgastrodin
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Acetylgastrodin is a small molecule drug used as a sedative, hypnotic, and analgesic. It is indicated for insomnia, neurasthenia (nervous exhaustion), vascular headache, and neurogenic headache. The drug works by restoring the balance between excitation and inhibition processes in the cerebral cortex, exerting central nervous system inhibitory effects[1][2][3].
- Brand names
- 乙酰天麻素片 (Yixie Tianmasu Pian)
- Other names
- 乙酰天麻素AcetagastrodinAcegastrodine
Beyond the preview
Go deeper on acetylgastrodin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on acetylgastrodin.